Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

BACKGROUND: The primary aim of this trial was to determine the recommended phase II dose (RP2D) of weekly paclitaxel (wP) administered in combination with oral metronomic cyclophosphamide (OMC). METHODS: Patients ≥ 18 years of age with refractory metastatic cancers were eligible if no standard curat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pannier, Diane, Adenis, Antoine, Bogart, Emilie, Dansin, Eric, Clisant-Delaine, Stéphanie, Decoupigny, Emilie, Lesoin, Anne, Amela, Eric, Ducornet, Sandrine, Meurant, Jean-Pierre, Le Deley, Marie-Cécile, Penel, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069824/
https://www.ncbi.nlm.nih.gov/pubmed/30064401
http://dx.doi.org/10.1186/s12885-018-4678-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069824/
https://www.ncbi.nlm.nih.gov/pubmed/30064401
http://dx.doi.org/10.1186/s12885-018-4678-x

Ejemplares similares